MedPath

Evaluation of the effects of Tamarind seed extract product (Tamarindus indica L.) with Sertraline in treatment of premature ejaculatio

Phase 3
Recruiting
Conditions
Premature ejaculation.
Premature ejaculation
F52.4
Registration Number
IRCT20140926019295N4
Lead Sponsor
Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Male
Target Recruitment
40
Inclusion Criteria

Being monogamous and married for at least 6 months ago
age between 50-20 years old
PEDT questionnaire score greater than 8
Written and informed consent to participate in the study

Exclusion Criteria

Use of treatments outside the study protocol
ulcerative colitis; Chronic constipation, digestive discomfort, kidney cleansing, high blood pressure
Not being able to accurately measure the IELT score
Chronic and permanent use of any type of psychoactive drug or any type of narcotic drug

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Time of Ejaculation ( From Vaginal Entrance to Ejaculation ). Timepoint: The Time of Ejaculation at the Beginning of the Study ( Before the Intervention) and 4 weeks after the start of Drug. Method of measurement: Measure the time in seconds by the stopwatch by the patient's wife.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath